Mtech's Mission

    The mission of the Maryland Technology Enterprise Institute (Mtech), a unit of the A. James Clark School of Engineering at the University of Maryland, is to:

    • Educate the next generation of technology entrepreneurs;
    • Create successful technology ventures; and
    • Connect Maryland companies with university resources to help them succeed.

    Mtech has built a comprehensive entrepreneurship and innovation ecosystem at the University of Maryland. Its programs arm top students from around the world with the knowledge of how to successfully launch companies and guide aspiring and existing entrepreneurs through the entire lifecycle of launching and maintaining technology-based ventures.

    Read more about Mtech >

    < MTECH


    ASPIRE is a grant program for undergraduate researchers working with Clark School faculty on projects with commercial potential

    Biopharmaceutical Advancement Facility

    The Biopharmaceutical Advancement Facility (BAF), founded in 2010, specializes in the development of cell culture-based biopharmaceutical products.

    Our services include:

    • Antibody and protein production
    • Scale-up and scale-down studies
    • Cell bank production and short-term storage
    • Cell clarification
    • Bioreactor process development

    Facility staff offers extensive experience with a range of cell lines: HEK293, CHO, Sf9, NSO, MSCs, and many other primary cell lines. In the time since its inception, the BAF has supported over 25 cell culture, stem cell, and recombinant biotherapeutic production projects.  The facility has also been integral in the prototype testing of several biomanufacturing technologies.

    The facility is not restricted by current good manufacturing practices (cGMPs); however, production processes are directly transferable to partners operating under cGMPs.

    Who is it for?


    Companies developing cell culture-based biopharmaceuticals or products


    Researchers looking for solutions to cell culture-based development changes


    Faculty needing a facility for, or expertise in, biopharmaceutical or cell culture-based research

    BAF's Advantages


    A unique facility in Maryland not restricted by current Good Manufacturing Practice (cGMP) requirements.


    Production processes are directly transferable to partners operating under cGMPs (required for FDA-approved clinical trials), such as Paragon Bioservices and Advanced Bioscience Labs.


    100% of undergraduates employed by the BAF go on to work in the  Biotech industry following graduation.


    The BAF enables small manufacturing companies to offer extended capabilities to major pharmaceutical (Big Pharma) companies out-of-state.

    Our Process Equipment Includes:

    • Static and shaking incubators
    • New Brunswick Bioflo310 Cell Culture Bioreactors, working volumes of 1.0, 3.5, 5.0 and 10.0
    • NBS Bioflow 5000 Mobile Pilot Bioreactor, 60 liter working volume
    • Hollow Fiber and Tangential Flow Filtration Systems

    Contact BAF

    Curtis Gallagher
    Interim Manager, Biopharmaceutical Advancement Facility
    Tel: (240) 314-6350

    Biopharmaceutical Advancement Facility

    Institute for Bioscience and Biotechnology Research (IBBR)
    9600 Gudelsky Drive
    Rockville, MD 20850